Clinical Trial Update: DC/NK Cell Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating DC/NK cell therapy for non-small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DC/NK cell therapy

Snippet

Sponsor: National Taiwan University Clinical Trial Center | Conditions: Lung Cancer (NSCLC) | Phase 2 | Status: RECRUITING